TY - JOUR
T1 - Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells
AU - Akagi, Tadayuki
AU - Yin, Dong
AU - Kawamata, Norihiko
AU - Bartram, Claus R
AU - Hofmann, Wolf-K
AU - Song, Jee Hoon
AU - Miller, Carl W
AU - den Boer, Monique L
AU - Koeffler, H Phillip
N1 - Funding Information:
We are grateful to Drs. Kent Taylor and Talin Haritunians for their discussion about statistical analysis. We are also thankful to members of our laboratory for helpful discussions. This work was supported by NIH grants as well as Parker Hughes Fund. H.P.K. is the holder of the Mark Goodson endowed Chair in Oncology Research and is a member of the Jonsson Cancer and Molecular Biology Institute, UCLA. The study is dedicated to David Golde, a mentor and friend.
PY - 2009/7
Y1 - 2009/7
N2 - Asparagine synthetase (ASNS) is an enzyme expressed ubiquitously in mammalian cells. Here, we discovered two 14-bp tandem repeat (2R, wild-type) sequences in the first intron of the gene. The 14-bp sequence is similar to the three GC-boxes (GC-I, -II, and -III) found in the promoter region of the ASNS gene, as well as, the binding site of transcription factor Sp-1. Approximately 75% of acute lymphoblastic leukemia (ALL) samples had the 2R sequence in both allele; however, 20% and 3% ALL samples had three (3R) and four (4R) 14-bp tandem repeats in one allele, respectively; the other allele had 2R. The tandem repeat sequence was not specific to the leukemia cells but represents a novel germline polymorphism. Interestingly, the 14-bp sequence functioned as a transcriptional enhancer element as shown by reporter analysis and formed a protein-DNA complex in vitro. Our data for the first time show that the ASNS gene has tandem repeated sequences as a polymorphism, and it can function as a transcriptional element; increased number of tandem repeat producing increased activity. Clinical significance in ALL requires further studies.
AB - Asparagine synthetase (ASNS) is an enzyme expressed ubiquitously in mammalian cells. Here, we discovered two 14-bp tandem repeat (2R, wild-type) sequences in the first intron of the gene. The 14-bp sequence is similar to the three GC-boxes (GC-I, -II, and -III) found in the promoter region of the ASNS gene, as well as, the binding site of transcription factor Sp-1. Approximately 75% of acute lymphoblastic leukemia (ALL) samples had the 2R sequence in both allele; however, 20% and 3% ALL samples had three (3R) and four (4R) 14-bp tandem repeats in one allele, respectively; the other allele had 2R. The tandem repeat sequence was not specific to the leukemia cells but represents a novel germline polymorphism. Interestingly, the 14-bp sequence functioned as a transcriptional enhancer element as shown by reporter analysis and formed a protein-DNA complex in vitro. Our data for the first time show that the ASNS gene has tandem repeated sequences as a polymorphism, and it can function as a transcriptional element; increased number of tandem repeat producing increased activity. Clinical significance in ALL requires further studies.
KW - Aspartate-Ammonia Ligase/genetics
KW - Base Sequence
KW - DNA, Neoplasm/genetics
KW - Electrophoretic Mobility Shift Assay
KW - Gene Expression Regulation, Enzymologic
KW - Humans
KW - Molecular Sequence Data
KW - Polymorphism, Genetic/genetics
KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/enzymology
KW - Promoter Regions, Genetic/genetics
KW - RNA, Messenger/genetics
KW - Sequence Homology, Nucleic Acid
KW - Tandem Repeat Sequences/genetics
KW - Tumor Cells, Cultured
UR - http://www.scopus.com/inward/record.url?scp=67349083536&partnerID=8YFLogxK
U2 - 10.1016/j.leukres.2008.10.022
DO - 10.1016/j.leukres.2008.10.022
M3 - Article
C2 - 19054556
SN - 0145-2126
VL - 33
SP - 991
EP - 996
JO - Leukemia research
JF - Leukemia research
IS - 7
ER -